These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12816114)

  • 1. Clinical trials in the face of adversity.
    Clodfelter K
    J Biolaw Bus; 2002; 5(3):34-8. PubMed ID: 12816114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More flexibility on reporting to federal agencies about injuries to research subjects.
    Maloney DM
    Hum Res Rep; 2002 Jan; 17(1):1-2. PubMed ID: 16270435
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse events reporting--the tip of an iceberg.
    Shamoo AE
    Account Res; 2001; 8(3):197-218. PubMed ID: 12481780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRBs, human subjects, and reporting adverse events.
    Maloney DM
    Hum Res Rep; 2005 Nov; 20(11):3. PubMed ID: 16358480
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial data: share and share alike?
    Mitka M
    JAMA; 2015 Mar; 313(9):881-2. PubMed ID: 25734721
    [No Abstract]   [Full Text] [Related]  

  • 6. How institutional review boards (IRBs) can handle adverse event reports.
    Maloney DM
    Hum Res Rep; 2006 Jan; 21(1):1-3. PubMed ID: 16789305
    [No Abstract]   [Full Text] [Related]  

  • 7. Restoring public trust in gene therapy.
    Kennedy EM
    J Biolaw Bus; 2001; 4(3):3-4. PubMed ID: 12962103
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy trials face further scrutiny.
    Greener M
    Mol Med Today; 2000 Jun; 6(6):211. PubMed ID: 10840374
    [No Abstract]   [Full Text] [Related]  

  • 9. Reporting of adverse events.
    Leape LL
    N Engl J Med; 2002 Nov; 347(20):1633-8. PubMed ID: 12432059
    [No Abstract]   [Full Text] [Related]  

  • 10. Researcher accused of not reporting adverse events: U.S. v. John S. Najarian (Part 1).
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):8. PubMed ID: 12731496
    [No Abstract]   [Full Text] [Related]  

  • 11. Protecting research subjects--what must be done.
    Shalala D
    N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
    [No Abstract]   [Full Text] [Related]  

  • 12. Children need more protection in clinical trials, says IOM. Panel concludes that current regulations are misapplied, but stops short of calling for strict enforcement.
    Ault A
    Lancet; 2004 Apr; 363(9415):1119. PubMed ID: 15068011
    [No Abstract]   [Full Text] [Related]  

  • 13. Public registration of clinical trials.
    Steinbrook R
    N Engl J Med; 2004 Jul; 351(4):315-7. PubMed ID: 15269307
    [No Abstract]   [Full Text] [Related]  

  • 14. Trial-results reporting and academic medical centers.
    Zarin DA; Tse T; Ross JS
    N Engl J Med; 2015 Jun; 372(24):2371-2. PubMed ID: 25992618
    [No Abstract]   [Full Text] [Related]  

  • 15. Making clinical trials safer for human subjects.
    Baram M
    Am J Law Med; 2001; 27(2-3):253-82. PubMed ID: 11467112
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory concerns in human gene therapy.
    Epstein SL
    Hum Gene Ther; 1991; 2(3):243-9. PubMed ID: 1751592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moral authority.
    Nature; 2013 Jun; 498(7452):5-6. PubMed ID: 23745195
    [No Abstract]   [Full Text] [Related]  

  • 18. Children as clinical research subjects.
    Chesney RW
    J Pediatr; 2005 May; 146(5):579-80. PubMed ID: 15870655
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of children and risks with medical devices.
    Maloney DM
    Hum Res Rep; 2004 Dec; 19(12):3. PubMed ID: 15810178
    [No Abstract]   [Full Text] [Related]  

  • 20. Panel backs pregnant women in trials.
    Anderson C
    Science; 1994 Mar; 263(5151):1216. PubMed ID: 8122099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.